Joseph L. Schocken - 04 Nov 2021 Form 3 Insider Report for Intelligent Medicine Acquisition Corp.

Role
Director
Signature
/s/ Joseph L. Schocken
Issuer symbol
N/A
Transactions as of
04 Nov 2021
Net transactions value
$0
Form type
3
Filing time
04 Nov 2021, 21:30:42 UTC
Next filing
10 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IQMD Class B Common Stock 04 Nov 2021 Class A Common Stock 25,000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As described in the issuer's registration statement on Form S-1 (File No. 333-260205) under the heading "Description of Securities--Founder Shares", the shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination on a one-for-one basis (subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like) and subject to certain anti-dilution rights and have no expiration date.

Remarks:

The reporting person has an indirect pecuniary interest in shares of Class B common stock of the issuer through membership interests in Intelligent Medicine Sponsor LLC over which the reporting person does not have voting or dispositive control